Milana Chamberlain and George Cameron ask: is it time for pharma to start using human rights language?
Milana Chamberlain and George Cameron
Advertisement
Articles by Milana Chamberlain and George Cameron
Advertisement
Latest Updated Articles
Human Rights on the Pharma Risk Management AgendaNovember 3rd 2016
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Enters $202 Million Agreement to Acquire Engage Bio
2
FDA Approves Datroway for Patients with Metastatic Triple-Negative Breast Cancer Who Are Not PD-1/PD-L1 Inhibitor Candidates
3
Eli Lilly and Novo Nordisk Shift Patients From Compounded Drugs to Lower-Cost Weight-Loss Pills: Report
4
The Evolving Relationship Between FDA and Biotech
5